Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

ClinicalTrials.gov ID: NCT03845400

Public ClinicalTrials.gov record NCT03845400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)

Study identification

NCT ID
NCT03845400
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Shire
Industry
Enrollment
168 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2019
Primary completion
Oct 21, 2022
Completion
Oct 21, 2022
Last update posted
Mar 29, 2023

2019 – 2022

United States locations

U.S. sites
23
U.S. states
20
U.S. cities
23
Facility City State ZIP Site status
Clinical Research Center of Alabama Birmingham Alabama 35209
Medical Research of Arizona Scottsdale Arizona 85248
University of California San Diego San Diego California 92122
AIRE Medical of Los Angeles Santa Monica California 90404
Asthma and Allergy Associates, PC Colorado Springs Colorado 80907
Yale University School of Medicine New Haven Connecticut 06519
University of South Florida Asthma, Allergy & Immunology Tampa Florida 33613
University of Kansas Medical Center Research Institute, Inc. Kansas City Kansas 66160
Institute for Asthma & Allergy - Chevy Chase Chevy Chase Maryland 20815
Massachusetts General Hospital Boston Massachusetts 02114-2752
University of Michigan Ann Arbor Michigan 48106
Mid West Immunology Clinic Plymouth Minnesota 55446
Washington University St Louis Missouri 63141
Riverside Medical Group, Belleville Belleville New Jersey 07109
Jay M Kashkin, MD Allergy, Asthma and Immunology Fair Lawn New Jersey 07410
Mount Sinai New York New York 10029
Clinical Research of Charlotte Charlotte North Carolina 28277
Duke Asthma, Allergy & Airway Center Durham North Carolina 27704
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45231
Portland Clinical Research/AAIM Care Happy Valley Oregon 97086
Penn State Hershey Medical Center Hershey Pennsylvania 17033
AARA Research Center Dallas Texas 75231
Seattle Allergy & Asthma Research Institute Seattle Washington 98115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03845400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03845400 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →